Author: xnewsline

Aspirin for Secondary Prevention in ASCVD: Evidence on Use Patterns and Balancing Ischemic Benefit vs Bleeding Risk

Aspirin (acetylsalicylic acid) is a cornerstone antiplatelet therapy used to reduce recurrent ischemic events in patients with established atherosclerotic cardiovascular disease (ASCVD). In secondary prevention—meaning prevention of future events in people with prior myocardial infarction, ischemic stroke, or established peripheral arterial disease—aspirin…Read More »